Livzon Pharmaceutical Group Inc 2023 AR2
The report highlights Livzon Pharmaceutical Group's performance in 2023, during which the company recorded an operating income of RMB 12,430.04 million and a net profit attributable to shareholders of RMB 1,953.65 million. The company achieved significant R&D milestones, with several innovative drugs and complex preparations approved for market launch, including Triptorelin Acetate Microspheres and Tocilizumab Injection. Notably, Livzon was awarded the highest AAA rating by MSCI ESG, becoming the first Chinese pharmaceutical company to achieve this distinction. Additionally, the company continued its social responsibility efforts through its Public Welfare Program for Prevention and Treatment of Chronic Diseases, benefiting nearly 20,000 patients across China.
Company: Livzon Pharmaceutical Group Inc
Sector: Health Care
Country: China
Year: 2023
Type: AR2
Pages: 498
Livzon Pharmaceutical Group Inc
Annual Report
The report highlights Livzon Pharmaceutical Group's performance in 2023, during which the company recorded an operating income of RMB 12,430.04 million and a net profit attributable to shareholders of RMB 1,953.65 million. The company achieved significant R&D milestones, with several innovative drugs and complex preparations approved for market launch, including Triptorelin Acetate Microspheres and Tocilizumab Injection. Notably, Livzon was awarded the highest AAA rating by MSCI ESG, becoming the first Chinese pharmaceutical company to achieve this distinction. Additionally, the company continued its social responsibility efforts through its Public Welfare Program for Prevention and Treatment of Chronic Diseases, benefiting nearly 20,000 patients across China.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees